Sponsors (2)
The bill increases transparency into Medicare and Medicaid fraud—potentially improving detection, deterring improper payments, and protecting beneficiaries and taxpayers—but imposes unfunded reporting burdens on OIG and raises reputational and resource trade-offs for providers and the agency.
Medicare and Medicaid beneficiaries and taxpayers: Quarterly public reports on investigations, prosecutions, alleged dollar amounts, and exclusions increase transparency about fraud, helping detect and deter improper payments.
Hospitals and health systems: Regular reporting of fraud trends gives providers data they can use to strengthen compliance programs and reduce improper billing.
Medicare and Medicaid programs: Increased oversight information may help protect program solvency and preserve benefits by enabling more effective identification of fraudulent payments.
HHS/OIG staff and federal oversight: Requiring quarterly reports without new funding increases reporting workload and may force reallocation of staff/time from other oversight activities.
Hospitals and providers: More frequent publicized data on alleged fraud can create reputational risk for providers who may be publicly implicated before allegations are proven.
Taxpayers: If OIG must divert resources to meet new reporting duties, other anti-fraud efforts could receive less attention, potentially reducing net fraud prevention.
Based on analysis of 2 sections of legislative text.
Requires HHS OIG to send quarterly reports to four congressional committees on Medicare and Medicaid fraud investigations, enforcement actions, alleged dollar amounts, and exclusions using existing funds.
Introduced October 31, 2025 by Aaron Bean · Last progress October 31, 2025
Requires the HHS Office of Inspector General (OIG) to send regular reports to four congressional committees on Medicare and Medicaid fraud investigations and enforcement. Reports must begin within three months of enactment, then occur at least quarterly for two years, and must include counts of investigations, prosecutions/civil actions, alleged dollar amounts, and the number of individuals or entities excluded from Federal health care programs for fraud-related conduct, using existing OIG funds.